Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome
Background. Obstructive sleep apnea syndrome (OSAS) is associated with systemic inflammation and increased risk of cardiovascular and chronic kidney disease. Cystatin C (Cyst C) is a novel biomarker of both latent renal damage and cardiovascular disease. Aim of the study was to measure serum levels...
Saved in:
Main Authors: | Kostas Archontogeorgis, Evangelia Nena, Christina Tsigalou, Athanasios Voulgaris, Maria Xanthoudaki, Marios Froudarakis, Paschalis Steiropoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/8081723 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
by: Konstantinos Archontogeorgis, et al.
Published: (2014-01-01) -
Coagulability in Obstructive Sleep Apnea
by: Christina Liak, et al.
Published: (2011-01-01) -
Association between elevated cystatin C levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis
by: Nianying Fu, et al.
Published: (2025-02-01) -
Sleep Endoscopy in the Evaluation of Pediatric Obstructive Sleep Apnea
by: Aaron C. Lin, et al.
Published: (2012-01-01) -
Respiratory Involvement in Patients with Neuromuscular Diseases: A Narrative Review
by: Athanasios Voulgaris, et al.
Published: (2019-01-01)